OCRF & Ovarian Cancer National Alliance are now one strong, united, inspiring voice!
Ovarian Cancer Research Fund (OCRF) and the Ovarian Cancer National Alliance (OCNA) have led the way in advocacy, research and support for patients and their families for over 22 years. As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Fund Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families. Read the exciting news!


Q&As with OCRF Researchers

Q&A with Tsz-Lun Yeung, Ph.D.

Dr. Tsz-Lun Yeung, Ph.D. is a 2011 Ann Schreiber Program of Excellence Grant Recipient. Sarah DeFeo: You were educated in Hong Kong. How did you end up doing research at MD Anderson Cancer Center in Houston? Tsz-Lun Yeung: I became interested in science in high school, and then studied molecular biology... 

Q&A with Sarah Adams, M.D., 2011 Liz Tilberis Awardee

Dr. Sarah Adams is a 2011 Liz Tilberis Grant Recipient. Sarah DeFeo: How did you end up becoming a gynecologic oncologist? Sarah Adams: Like many people, I didn’t always know this is what I wanted to do.  After college, I did volunteer work with AmeriCorps.  I was committed to service, and became... 

2011 SGO News: GI Risk Clarified for Bevacizumab

Ovarian cancer patients had a twofold greater risk of gastrointestinal adverse effects when bevacizumab was added to chemotherapy, but the angiogenesis inhibitor did not exacerbate other known risks for GI events, data from a large prospective trial showed. Treatment with bevacizumab was associated...